Logo
Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome to ShareScene - Talk Shares And Take Stock With Australia's Sharemarket Community - New Here? Click To Register >

Important Notice For All Members - ShareScene Is Moving

4245 Pages (Click to Jump) V   1 2 3 4 > »    
 
  
Reply to this topic

CUV, CLINUVEL PHARMACEUTICALS LIMITED
sharelooker
post Posted: Yesterday, 11:12 PM
  Quote Post


Posts: 327
Thanks: 1213


In Reply To: royco's post @ Yesterday, 09:08 PM

The advisory committee meeting was already mentioned in the March newsletter and it's quite common for a NME like SC. So i don't think it's gonna have much impact on the length of the review process.


Said 'Thanks' for this post: royco  
 
royco
post Posted: Yesterday, 09:08 PM
  Quote Post


Posts: 2,829
Thanks: 4239


Left on the end of 2018 promise list of our CEO:-vitiligo singapore results-announcement of a new indication for SCENESSE
Maybe I forgot something but I suppose those are the most important ones.
I do not expect them to come forward with any news without having the FDA validating the file.Now that the CEO has hinted on an advisory committee meeting I fear that the FDA will drag this out deep into 2019 and a decision in 2020.So I expect them to go quiet on the launch of the cosmetic line in 2019.The only thing they are doing at the moment is to increase the EU distribution.







--------------------
Ἀρτεμίσιον

Said 'Thanks' for this post: odi01  
 
investek
post Posted: Yesterday, 08:54 PM
  Quote Post


Posts: 167
Thanks: 656


In Reply To: Verharven's post @ Yesterday, 06:51 PM

Fair point Verharven, thanks for pointing out my oversight/sloppy language.

For completeness, this quarter S&P/ASX 200 Index – No change.

And for those interested in the specific differences between the indexes mentioned;

The S&P/ASX 200 is recognized as the institutional investable benchmark in Australia. Index constituents are drawn from eligible companies listed on the Australian Securities Exchange. The S&P/ASX 200 is designed to measure the performance of the 200 largest index-eligible stocks listed on the ASX by float-adjusted market capitalization. Representative, liquid, and tradable, it is widely considered Australia’s preeminent benchmark index.
https://au.spindices.com/indices/equity/sp-asx-200

The S&P/ASX All Australian 200 (AUD) Index follows the same methodology with respect to market capitalization and liquidity that are applied to the S&P/ASX 200 with one distinguishing characteristic - the rules do not extend index eligibility to foreign domiciled securities listed on the ASX. This allows the S&P/ASX All Australian Indices to be more fully representative of the characteristics of Australian listed companies.
https://au.spindices.com/indices/equity/sp-...-australian-200

October 2018 Foreign Entity Data can be found in the link below
https://www.asx.com.au/documents/resources/...t-20181031.xlsx


Said 'Thanks' for this post: sharelooker  
 
Verharven
post Posted: Yesterday, 06:51 PM
  Quote Post


Posts: 542
Thanks: 1284


In Reply To: investek's post @ Yesterday, 09:52 AM

Just saw this post after mine and noted your comment about Copper Energy, but that was the All Australian S&P/ASX200 index so different to the straight S&P/ASX200 index which is where we want to be as is where all the index funds and the like are playing


Said 'Thanks' for this post: sharelooker  investek  
 
Verharven
post Posted: Yesterday, 06:46 PM
  Quote Post


Posts: 542
Thanks: 1284


S&P/ASX200 rebalance announcement shows no change to the index. Not of course that CUV had a chance of being added at this stage, but is nearing the zone for inclusion as currently sitting at position 180 on the ASX200 (needs to be at position 179 or better plus some other factors and also that there is a vacancy from an exclusion) so a good quarter with SP appreciation and good volume could be a chance in 3 months

https://www.spice-indices.com/idpfiles/spic...e_download=true


Said 'Thanks' for this post: xray  sharelooker  9 lives  odi01  
 
investek
post Posted: Yesterday, 09:52 AM
  Quote Post


Posts: 167
Thanks: 656


In Reply To: waz's post @ Dec 1 2018, 03:41 PM

As you predicted Waz, CUV has fallen short of inclusion in the ASX200 this rebalance.
https://www.asx.com.au/asxpdf/20181214/pdf/...6z7xvngbz8v.pdf

Interesting to note that Cooper Energy COE(ASX) was added with a current market cap of ~$700mil (vs CUVs ~$850mil market cap today). I haven’t run the numbers however I believe liquidity could be the difference with COE almost twice as liquid as CUV?

Let’s see what happens in March...


Said 'Thanks' for this post: johnnytech  polyphemus  waz  xray  
 


Johnny H
post Posted: Yesterday, 05:09 AM
  Quote Post


Posts: 384
Thanks: 452


In Reply To: odi01's post @ Yesterday, 03:26 AM

By Giles Delaney*




*Not real



--------------------
Clinuvel until my bowels release for the last time.

Said 'Thanks' for this post: macgyver  
 
mrdax
post Posted: Yesterday, 04:39 AM
  Quote Post


Posts: 197
Thanks: 288


In Reply To: odi01's post @ Yesterday, 03:26 AM

Very enlightening as always.
Joy to read.
[Sarcasm off]


Said 'Thanks' for this post: macgyver  
 
odi01
post Posted: Yesterday, 03:26 AM
  Quote Post


Posts: 477
Thanks: 1297


https://www.clinuvel.com/social-media/subq/...iness-execution


Said 'Thanks' for this post: waz  
 
seeva222
post Posted: Dec 13 2018, 02:23 PM
  Quote Post


Posts: 1,126
Thanks: 1192


“As the number of European centres and countries is expanding, we are looking forward to a successful year whereby more EPP patients will gain access to the innovative medication.” Any insight into the new centres and countries coming on line?


 
 


4245 Pages (Click to Jump) V   1 2 3 4 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING